Arrange urgent medical assessment
Is Bleeding Blocking the Bladder or Causing Significant Blood Loss?
Seek urgent care for:
- Inability to pass urine with a painful, swollen lower abdomen—blood clots may be blocking the bladder outlet.
- Heavy ongoing bleeding, repeated large clots, faintness, marked weakness, breathlessness or chest discomfort.
- Fever, shaking chills, confusion, vomiting or severe illness after cystoscopy, TURBT, catheterisation or intravesical treatment.
- Severe flank pain, very little urine or known obstruction affecting the kidneys.
- New severe pelvic or bone pain, leg weakness or rapidly worsening general health in someone with known bladder cancer.
Visible blood in urine without clots or systemic illness still requires prompt urological evaluation, even if it clears by itself. The absence of pain does not make bleeding harmless.
What is Bladder Cancer?
The bladder stores urine produced by the kidneys. Its inner surface is lined by urothelial cells that stretch as the bladder fills. Most bladder cancers arise from this lining and are called urothelial carcinomas.
The older word “superficial” can be misleading because some non-muscle-invasive cancers are high grade and clinically serious. The pathology report's depth and grade are more useful.
What Symptoms Can Bladder Cancer Cause?
Many of these symptoms have benign causes such as infection, stones, BPH or medicines. Investigation is needed because symptoms alone cannot safely distinguish them from cancer.
Why Must Blood in Urine Be Investigated?
Bladder tumours can bleed intermittently. Urine may look completely normal between episodes, and the bleeding may stop before an appointment. This does not show that the cause has resolved.
- Visible blood may be bright red, pink, smoky, cola-coloured or accompanied by clots.
- Anticoagulants can increase bleeding but do not explain away the underlying source.
- A urine infection can coexist with cancer; persistent or recurrent blood after treatment needs evaluation.
- A normal ultrasound does not reliably exclude a small or flat bladder tumour.
- Urine cytology can miss low-grade tumours and does not replace cystoscopy.
One Painless Episode Still Matters
Do not wait for bleeding to become continuous. Record the colour, clots, timing, pain, medicines and urinary symptoms, but arrange assessment even if the urine has cleared.
Who Has a Higher Risk?
People who have never smoked can still develop bladder cancer. Risk factors guide clinical suspicion; they are not required before haematuria is investigated.
Questions Your Doctor May Ask
What did the blood look like?
Colour, clots, pain, timing within the urine stream, duration and recurrence help assess urgency. Photographs can be useful if the urine has returned to normal before consultation.
Is infection or stone disease possible?
Fever, burning, frequency, flank pain, previous stones and urine-culture results help identify conditions that may coexist with or mimic a tumour.
What are the smoking and occupational histories?
Current and previous tobacco exposure and work with dyes, rubber, leather, paint, petroleum, printing or industrial chemicals may alter risk even many years later.
Which medicines and previous treatments matter?
Anticoagulants, antiplatelet medicines, prior systemic chemotherapy, pelvic radiotherapy, catheters and previous urinary procedures affect interpretation and procedural planning.
Has there been a previous urothelial tumour?
Bring earlier cystoscopy, TURBT, pathology, intravesical-treatment and follow-up records. Number, grade, depth, CIS and time to recurrence determine the current risk assessment.
How is Suspected Bladder Cancer Investigated?
Urinalysis, microscopy and culture look for blood and infection. Blood counts, kidney function and other tests assess anaemia and procedural or contrast safety.
Ultrasound or CT urography examines kidneys, ureters and bladder for tumours, stones, obstruction and alternative bleeding sources. The choice reflects age, risk and kidney function.
A thin camera passes through the urethra to examine the bladder lining directly. Flexible cystoscopy is commonly performed with local anaesthetic gel.
TURBT is performed under anaesthesia when a tumour is seen. It removes visible growth and provides tissue to confirm type, grade and depth.
The urology or multidisciplinary team combines TURBT findings, pathology and appropriate imaging. Treatment intensity and follow-up depend on stage and recurrence risk.
What Happens During Cystoscopy?
During flexible cystoscopy, antiseptic preparation and anaesthetic gel are applied before a slender camera passes through the urethra. Sterile fluid gently fills the bladder so its surface can be inspected. The procedure is brief, and most patients go home soon afterwards.
Mild burning, frequency or a small amount of blood can occur temporarily. Drink according to the team's advice and seek help for fever, worsening pain, inability to urinate or heavy bleeding. A normal cystoscopy may still be combined with upper-tract imaging when the haematuria assessment requires it.
Special light or image-enhancement techniques may help identify subtle lesions in selected cases. Urinary biomarker tests and cytology can support assessment but do not routinely substitute for direct inspection.
What is TURBT?
TURBT means transurethral resection of bladder tumour. It is performed through the natural urine passage, so there is usually no skin incision. Under spinal or general anaesthesia, the surgeon passes a telescope into the bladder and uses a fine electrical loop or another endoscopic instrument to remove tumour.
A catheter may remain for a short time to drain urine and manage bleeding. Selected patients receive a single dose of chemotherapy into the bladder soon after TURBT, provided there is no concern about perforation or heavy bleeding.
Read the detailed TURBT procedure guide →What Should You Expect After TURBT?
- Burning, urgency and pink urine are common for a limited period.
- Small scabs can separate during healing and cause a temporary return of light bleeding.
- Avoid strenuous activity and follow the team's fluid, catheter and medicine instructions.
- Do not restart interrupted blood-thinning medicines until the treating team advises.
- Seek urgent help for thick bleeding, large clots, inability to urinate, fever or worsening pain.
Less common complications include urinary infection, significant bleeding, retention and a hole in the bladder wall. Most small perforations heal with catheter drainage; larger injury may require additional treatment.
A second TURBT may be advised when the first removal was incomplete, bladder muscle is absent from an important specimen, or the cancer has high-risk features. This improves confidence in depth assessment and tumour clearance.
What Does the Pathology Report Tell Us?
Tumour size, number, previous recurrence and response to earlier bladder treatment are combined with pathology. A single word such as “small” or “superficial” is not enough to define risk.
How is Bladder Cancer Treated?
Treatment depends on how deeply the cancer has grown, whether it is low or high grade, whether it is single or recurrent, imaging findings, general health and the patient's priorities. The plan is reviewed after TURBT pathology.
Radical cystectomy means removing the bladder and creating a new route for urine. One common option is an ileal conduit, which uses a short isolated segment of small bowel to carry urine to a stoma and external bag. If this becomes relevant, the surgical and stoma teams provide a much fuller individual discussion.
What is Intravesical Treatment?
“Intravesical” means medicine is placed directly inside the bladder through a small catheter and retained for an advised time. It treats the bladder lining while limiting whole-body exposure. The choice and schedule depend on risk.
- Intravesical chemotherapy can reduce implantation and recurrence after TURBT.
- Intravesical immunotherapy stimulates a local immune response and is used for selected high-risk non-muscle-invasive disease.
- Temporary frequency, urgency, burning, blood and bladder discomfort can occur.
- Treatment may be delayed for urinary infection, traumatic catheterisation or significant visible bleeding.
- Persistent fever or severe illness after intravesical immunotherapy requires urgent medical contact because serious systemic infection is rare but possible.
Intravesical treatment is not the same as intravenous chemotherapy. Patients should receive written instructions about preparation, urine handling, adverse effects and when to seek help for the specific medicine used.
Why is Follow-up So Important?
Bladder cancer can recur in another part of the bladder lining, even after a complete TURBT. Some recurrences remain low grade; others can return at a higher grade or progress into muscle. Follow-up is therefore part of treatment.
Surveillance may include:
- Scheduled cystoscopy, with frequency based on the patient's recurrence and progression risk.
- Urine cytology for selected higher-risk disease.
- Imaging of kidneys and ureters when the risk or symptoms justify it.
- Repeat TURBT or biopsy if a suspicious lesion is seen.
- Assessment of urinary function and late treatment effects.
Do not wait for the next routine visit if visible blood, new urinary symptoms, flank pain or unexplained decline develops. Contact the urology team because earlier assessment may change management.
Can Bladder Cancer Be Prevented?
- Stop smoking; benefit extends to cardiovascular, lung, surgical and treatment health.
- Use workplace protective measures and follow occupational-health guidance for chemical exposure.
- Maintain appropriate hydration, although drinking water cannot guarantee prevention or cure.
- Seek assessment for recurrent visible blood rather than repeatedly assuming infection.
- Attend every scheduled cystoscopy after diagnosis, even when urine looks normal.
- Avoid unproven supplements marketed as tumour-cleansing treatments.
Smoking cessation after diagnosis remains worthwhile and may improve general health, treatment fitness and the risk of further urothelial tumours. Support with counselling and medication can be more effective than willpower alone.
Myth vs Fact
Frequently Asked Questions
Does blood in urine always mean bladder cancer?
No. Infection, stones, prostate disease, kidney conditions, medicines and several other causes are common. Because bladder and kidney cancers can also bleed intermittently, visible haematuria still requires a structured assessment.
Can bladder cancer be cured?
Many non-muscle-invasive cancers can be removed and controlled, although recurrence requires surveillance. Muscle-invasive cancer can also be treated with curative intent in suitable patients. Outlook depends on depth, grade, spread, general health and response.
Will TURBT leave a cut on my abdomen?
Usually not. The telescope and resection instrument pass through the urethra into the bladder. A catheter may remain temporarily, and the internal resection area heals over the following weeks.
Why might I need a second TURBT?
Repeat resection can remove residual tumour and improve depth assessment when the first procedure was incomplete, high-risk cancer was found or adequate bladder muscle was not included in an important specimen.
What symptoms after intravesical immunotherapy need urgent review?
Persistent fever, shaking chills, marked weakness, breathlessness or rapidly worsening illness requires urgent medical advice. Follow the treatment unit's specific safety and contact instructions.
Why do I need more cystoscopies after the tumour is removed?
Urothelial cancer can recur elsewhere in the bladder lining. Cystoscopy identifies small recurrences before they cause heavy bleeding or progress. The schedule is individualised according to the original tumour and subsequent findings.
Can anticoagulants be the only reason for blood in urine?
They can make bleeding more noticeable but should not be assumed to be the sole cause. The urinary tract still needs appropriate evaluation. Never stop anticoagulants without advice from the prescribing and procedural teams.